The dysregulation of protein kinases plays critical roles in numerous human diseases, including cancers, inflammatory diseases, central nervous system disorders, cardiovascular diseases, and complications of diabetes, therefore protein kinases become an important source of potential drug targets [1]. This evidence concerns the gene WEE1 and diabetes mellitus.